Filing Details
- Accession Number:
- 0001395064-21-000142
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-29 06:44:10
- Reporting Period:
- 2021-06-25
- Accepted Time:
- 2021-06-29 06:44:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1783183 | Phathom Pharmaceuticals Inc. | PHAT | Pharmaceutical Preparations (2834) | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1395064 | Takeda Pharmaceutical Co Ltd | 1-1, Nihonbashi-Honcho 2-Chome Chuo-Ku, Tokyo M0 103-8668 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-25 | 22,881 | $35.46 | 883,860 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-25 | 1,250 | $36.07 | 882,610 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-28 | 370 | $35.08 | 882,240 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 2, 2021.
- Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.97. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
- Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $36.00 to $36.16. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
- Reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.21. Information regarding the number of shares sold at each separate price will be provided upon request by the Staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer.
Billionaire Hedge Funds
